Oral cancer/endothelial cell fusion experiences nuclear fusion and acquisition of enhanced survival potential

Experimental Cell Research

Volumn 328, Issue 1, 2014, Pages 156-163

  Song, Kai ^a,b   Song, Yong ^b,c   Zhao, Xiao Ping ^b   Shen, Hui ^b   Wang, Meng ^b   Yan, Ting lin ^b   Liu, Ke ^b   Shang, Zheng jun ^b  

^a QINGDAO UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c LIUZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Cell fusion; Chemoresistance; EGFP; Endothelial cell; Nuclear fusion; Oral cancer; RFP

Indexed keywords

CISPLATIN; CYTOKERATIN 18; PUROMYCIN; VIMENTIN; ANTINEOPLASTIC AGENT; KRT18 PROTEIN, HUMAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER SURVIVAL; CELL FUSION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HYBRID CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NICK END LABELING; NONHUMAN; NUCLEAR ENERGY; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CYTOLOGY; DRUG EFFECTS; DRUG RESISTANCE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; MOUTH NEOPLASMS; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL FUSION; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYBRID CELLS; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATIN-18; MICE; MICE, NUDE; MOUTH NEOPLASMS; NUCLEAR FUSION; TUMOR CELLS, CULTURED; VIMENTIN;

EID: 84908010905     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.07.006     Document Type: Article

References (27)

1. Pawelek J.M. Cancer-cell fusion with migratory bone-marrow-derived cells as an explanation for metastasis: new therapeutic paradigms. Future Oncol. 2008, 4:449-452.
2. Ding J., Jin W., Chen C., Shao Z., Wu J. Tumor associated macrophage×cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One 2012, 7:e41942.
3. Nagler C., Hardt C., Zanker K.S., Dittmar T. Co-cultivation of murine BMDCs with 67NR mouse mammary carcinoma cells give rise to highly drug resistant cells. Cancer Cell Int. 2011, 11:21.
4. Rappa G., Mercapide J., Lorico A. Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am. J. Pathol. 2012, 180:2504-2515.
5. Duelli D.M., Lazebnik Y.A. Primary cells suppress oncogene-dependent apoptosis. Nat. Cell Biol. 2000, 2:859-862.
6. Noman M.Z., Messai Y., Carre T., Akalay I., Meron M., Janji B., Hasmim M., Chouaib S. Microenvironmental hypoxia orchestrating the cell stroma cross talk, tumor progression and antitumor response. Crit. Rev. Immunol. 2011, 31:357-377.
7. Mortensen K., Lichtenberg J., Thomsen P.D., Larsson L.I. Spontaneous fusion between cancer cells and endothelial cells. Cell. Mol. Life Sci. 2004, 61:2125-2131.
8. Gao W., Guo C.B. Factors related to delay in diagnosis of oral squamous cell carcinoma. J. Oral Maxillofac. Surg. 2009, 67:1015-1020.
9. Song K., Zhu F., Zhang H.Z., Shang Z.J. Tumor necrosis factor-alpha enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway. Exp. Cell Res. 2012, 318:1707-1715.
10. Chen G., Zhang W., Li Y.P., Ren J.G., Xu N., Liu H., Wang F.Q., Sun Z.J., Jia J., Zhao Y.F. Hypoxia-induced autophagy in endothelial cells: a double-edged sword in the progression of infantile haemangioma?. Cardiovasc. Res. 2013, 98:437-448.
11. Busund L.T., Killie M.K., Bartnes K., Olsen R., Seljelid R. Spontaneous hybridization of macrophages and Meth A sarcoma cells. Int. J. Cancer 2002, 98:573-581.
12. Dittmar T., Schwitalla S., Seidel J., Haverkampf S., Reith G., Meyer-Staeckling S., Brandt B.H., Niggemann B., Zanker K.S. Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin. Exp. Metastasis 2011, 28:75-90.
13. Bjerregaard B., Holck S., Christensen I.J., Larsson L.I. Syncytin is involved in breast cancer-endothelial cell fusions. Cell. Mol. Life Sci. 2006, 63:1906-1911.
14. Lu X., Kang Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc. Natl. Acad Sci. U. S. A. 2009, 106:9385-9390.
15. Ozel C., Seidel J., Meyer-Staeckling S., Brandt B.H., Niggemann B., Zanker K.S., Dittmar T. Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk. Cell Commun. Signal. 2012, 10:10.
16. Zhang S., Shpall E., Willerson J.T., Yeh E.T. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ. Res. 2007, 100:693-702.
17. Christiansen J.J., Rajasekaran A.K. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res. 2006, 66:8319-8326.
18. Lundgren K., Nordenskjold B., Landberg G. Hypoxia, snail and incomplete epithelial-mesenchymal transition in breast cancer. Br. J. Cancer 2009, 101:1769-1781.
19. Lecharpentier A., Vielh P., Perez-Moreno P., Planchard D., Soria J.C., Farace F. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 2011, 105:1338-1341.
20. Sung C.O., Park C.K., Kim S.H. Classification of epithelial-mesenchymal transition phenotypes in esophageal squamous cell carcinoma is strongly associated with patient prognosis. Mod. Pathol. 2011, 24:1060-1068.
21. Rachkovsky M., Sodi S., Chakraborty A., Avissar Y., Bolognia J., McNiff J.M., Platt J., Bermudes D., Pawelek J. Melanoma×macrophage hybrids with enhanced metastatic potential. Clin. Exp. Metastasis 1998, 16:299-312.
22. Yang J.Y., Ha S.A., Yang Y.S., Kim J.W. p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance. BMC Cancer 2010, 10:388.
23. Lu X., Kang Y. Cell fusion as a hidden force in tumor progression. Cancer Res. 2009, 69:8536-8539.
24. Carloni V., Mazzocca A., Mello T., Galli A., Capaccioli S. Cell fusion promotes chemoresistance in metastatic colon carcinoma. Oncogene 2013, 32:2649-2660.
25. Goldenberg D.M., Gold D.V., Loo M., Liu D., Chang C.H., Jaffe E.S. Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology. PLoS One 2013, 8:e55324.
26. Powell A.E., Anderson E.C., Davies P.S., Silk A.D., Pelz C., Impey S., Wong M.H. Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res. 2011, 71:1497-1505.
27. Mercapide J., Rappa G., Lorico A. The intrinsic fusogenicity of glioma cells as a factor of transformation and progression in the tumor microenvironment. Int. J. Cancer 2012, 131:334-343.